Barrington lowered the firm’s price target on Stoneridge (SRI) to $16 from $20-$25 and keeps an Outperform rating on the shares. The company’s Q3 came in weaker than expected and 2024 guidance was reduced as market challenges continue, the analyst tells investors in a research note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter